Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pirprofen.

R E Dionne, S S Weber

    Drug Intelligence & Clinical Pharmacy
    |December 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Pirprofen, a nonsteroidal anti-inflammatory drug (NSAID), effectively manages rheumatoid arthritis and osteoarthritis symptoms. It offers comparable efficacy and tolerability to other NSAIDs, presenting a viable alternative for patients intolerant to existing treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The human platelet alloantigen profile in blood donors from Amazonas, Brazil.

    Transfusion medicine (Oxford, England)·2016
    Same author

    Sulpiride: an antipsychotic with selective dopaminergic antagonist properties.

    The Annals of pharmacotherapy·1995
    Same author

    Paroxetine: a selective serotonin reuptake inhibiting antidepressant.

    The Annals of pharmacotherapy·1993
    Same author

    Effect of use of generic thioridazine products on clinical outcome and quality of life.

    Clinical pharmacy·1991
    Same author

    Clozapine: a novel antipsychotic agent.

    DICP : the annals of pharmacotherapy·1989
    Same author

    Nadolol in the treatment of aggressive behavior associated with schizophrenia.

    Clinical pharmacy·1989
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Area of Science:

    • Pharmacology
    • Rheumatology

    Background:

    • Pirprofen is an investigational nonsteroidal anti-inflammatory drug (NSAID).
    • It is being evaluated for rheumatoid arthritis, osteoarthritis, and analgesic applications.

    Purpose of the Study:

    • To assess the efficacy and tolerability of pirprofen compared to existing NSAIDs.
    • To determine optimal dosage regimens for pirprofen in specific inflammatory conditions.

    Main Methods:

    • Clinical investigation of pirprofen in Phase III trials.
    • Comparative analysis of pirprofen against aspirin and other NSAIDs regarding symptom relief and adverse effects.

    Main Results:

    • Pirprofen (600-800 mg/d) demonstrated comparable efficacy to aspirin (3.6 g/d) for rheumatoid arthritis symptom management.

    Related Experiment Videos

  • Pirprofen showed similar efficacy, tolerability, and adverse effect profiles to other NSAIDs.
  • Gastrointestinal side effects, including peptic ulceration, were reported in a small percentage of patients.
  • Central nervous system side effects, common with high-dose aspirin, were less frequent with pirprofen.
  • Conclusions:

    • Pirprofen is an effective therapeutic option for rheumatoid arthritis and osteoarthritis.
    • It provides an alternative for patients who cannot tolerate aspirin or other NSAIDs.
    • While not offering distinct advantages, pirprofen presents a comparable safety and efficacy profile.